Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Galiximab (IDEC 114), a primatized IgG1 lambda monoclonal antibody, targets the CD80 antigen. It combines primatized (cynomologous monkeys) variable regions with human constant regions. This compound is utilized in the study of B-cell lymphoma [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Galiximab (IDEC 114), a primatized IgG1 lambda monoclonal antibody, targets the CD80 antigen. It combines primatized (cynomologous monkeys) variable regions with human constant regions. This compound is utilized in the study of B-cell lymphoma [1]. |
Molecular Weight | N/A |
CAS No. | 357613-77-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Galiximab 357613-77-5 inhibitor inhibit